Literature DB >> 9506554

End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.

R L Ruff1, V A Lennon.   

Abstract

This study examined the loss of voltage-gated Na+ channels as well as acetylcholine receptors (AChRs) from the end-plate region in patients with acquired myasthenia gravis (MG) and in rats with experimental autoimmune passively transferred MG (PTMG). Rats received a monoclonal IgG antibody directed against an extracellular epitope of the nicotinic acetylcholine receptor of muscle (AChR) to produce PTMG. At the end-plate border we examined miniature end-plate potentials (MEPPs), sodium current (INa) amplitude, and action potential (AP) properties; the latter two were also examined on the extrajunctional membrane. In the normal situation, the safety factor for neuromuscular transmission is ensured by the large INa at the end plate, which reduces the AP threshold. Among different fiber types, INa was largest for type IIb fibers and smallest for type I fibers. When end-plate border properties of fibers from 3 MG patients and 15 PTMG rats were compared with controls, INa was reduced, AP thresholds were higher, and rates of AP rise were reduced. Amplitudes of MEPPs and INa at the end plate indicated that loss of AChRs was greater than loss of Na+ channels in patients with MG and rats with PTMG; INa was reduced to about 60% of control values, whereas MEPPs were reduced to less than 30% of control values. On the extrajunctional membrane, INa and AP thresholds and rates of rise were similar for MG patients, PTMG rats, and controls. This evidence for loss of voltage-gated Na+ channels at the motor end plate in both patients with MG and in rats with PTMG reveals a hitherto unrecognized consequence of the end-plate damage initiated by the binding of complement-fixing IgG to end-plate AChRs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506554     DOI: 10.1002/ana.410430315

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy.

Authors:  Mark M Rich; Martin J Pinter
Journal:  J Physiol       Date:  2003-01-24       Impact factor: 5.182

2.  Measurement of contractile force of skeletal and extraocular muscles: effects of blood supply, muscle size and in situ or in vitro preparation.

Authors:  Scott A Croes; Christopher S von Bartheld
Journal:  J Neurosci Methods       Date:  2007-07-04       Impact factor: 2.390

Review 3.  Dysregulation of sodium channel gating in critical illness myopathy.

Authors:  James W Teener; Mark M Rich
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

Review 4.  Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles.

Authors:  Alessandro Serra; Robert L Ruff; Richard John Leigh
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

5.  Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome.

Authors:  W David Arnold; Daniel H Feldman; Sandra Ramirez; Liuyuan He; Darine Kassar; Adam Quick; Tara L Klassen; Marian Lara; Joanna Nguyen; John T Kissel; Christoph Lossin; Ricardo A Maselli
Journal:  Ann Neurol       Date:  2015-03-27       Impact factor: 10.422

6.  Identification of neuromuscular junctions by correlative confocal and transmission electron microscopy.

Authors:  Shannon Modla; Janet Mendonca; Kirk J Czymmek; Robert E Akins
Journal:  J Neurosci Methods       Date:  2010-06-25       Impact factor: 2.390

7.  How myasthenia gravis alters the safety factor for neuromuscular transmission.

Authors:  Robert L Ruff; Vanda A Lennon
Journal:  J Neuroimmunol       Date:  2008-07-15       Impact factor: 3.478

8.  RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment.

Authors:  Yuefang Zhou; Henry J Kaminski; Bendi Gong; Georgiana Cheng; Jason M Feuerman; Linda Kusner
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-10       Impact factor: 4.799

9.  Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology.

Authors:  Noa Farchi; Hermona Soreq; Binyamin Hochner
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

10.  Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs.

Authors:  Mario Losen; Pilar Martinez-Martinez; Peter C Molenaar; Konstantinos Lazaridis; Socrates Tzartos; Talma Brenner; Rui-Sheng Duan; Jie Luo; Jon Lindstrom; Linda Kusner
Journal:  Exp Neurol       Date:  2015-03-18       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.